ImageONE Valuation
Is 2667 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 2667 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 2667's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 2667's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2667?
Key metric: As 2667 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 2667's PS Ratio? | |
|---|---|
| PS Ratio | 1.4x |
| Sales | JP¥1.65b |
| Market Cap | JP¥2.27b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | -2.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2667's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.4x | ||
4438 Welby | 5.8x | n/a | JP¥3.1b |
4172 TOWA Hi SYSTEMLTD | 2x | 19.6% | JP¥4.1b |
3628 Data HorizonLtd | 1x | n/a | JP¥5.1b |
3671 Softmax | 0.9x | n/a | JP¥5.1b |
2667 ImageONE | 1.4x | n/a | JP¥2.3b |
Price-To-Sales vs Peers: 2667 is good value based on its Price-To-Sales Ratio (1.4x) compared to the peer average (2.4x).
Price to Sales Ratio vs Industry
How does 2667's PS Ratio compare vs other companies in the JP Healthcare Services Industry?
| 0 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: 2667 is good value based on its Price-To-Sales Ratio (1.4x) compared to the JP Healthcare Services industry average (2.4x).
Price to Sales Ratio vs Fair Ratio
What is 2667's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 2667's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
TOWA Hi SYSTEMLTD
JP¥4.1b
Develops medical software solutions in Japan.
4172
JP¥1,858.00
7D
0.05%
1Y
16.2%
FINDEX
JP¥20.2b
Offers medical systems, office systems, and Healthtech products in Japan.
3649
JP¥786.00
7D
-3.2%
1Y
-17.4%
TOKAI
JP¥73.2b
Provides various healthy life services in Japan.
9729
JP¥2,163.00
7D
-2.6%
1Y
13.0%